-
Cagrilintide and SemaglutideCagrilintide (CAS 1415456-99-3) is a long‑chain acylated amylin analogue and a dual agonist of amylin and calcitonin receptors. CAS Number 1415456-99-3 Formularead more
-
Terlipressin FDATerlipressin API (Terlipressin Active Pharmaceutical Ingredient) is a synthetic long-acting vasopressin analog with the chemical identifier CAS 14636-12-5. It is a core raw material for critical careread more
-
Semaglutide Raw MaterialSemaglutide is a new-generation long-acting GLP-1 receptor agonist API. With the CAS number 910463-68-2, it appears as a white to off-white crystalline powder. CAS Number 910463-68-2read more
-
Carbetocin APICarbetocin (CAS 37025-55-1) is a long-acting synthetic oxytocin analog and a classic pharmaceutical raw material in polypeptide synthesis. With years of clinical validation and process optimization,read more
-
Atosiban APIAtosiban (CAS 90779-69-4) is a high-purity Atosiban API and polypeptide raw material for pharmaceutical use, acting as an effective oxytocin receptor antagonist for anti-preterm birth drugread more
-
Epalrestat FDAEpalrestat CAS 82159-09-9 is the only globally marketed aldose reductase inhibitor API, first-line treatment for diabetic peripheral neuropathy. It blocks the polyol pathway, reduces sorbitolread more
-
Finerenone APIFinerenone API (CAS 1050477-31-0) is a new-generation nonsteroidal cardiorenal protective drug substance with highly selective mineralocorticoid receptor antagonism, providing core pharmaceutical rawread more
-
Estradiol APIOur estradiol API series consists of key steroidal estrogen raw materials, including natural endogenous estradiol API (CAS 50-28-2), synthetic potent Estradiol valerate (CAS 979-32-8), andread more
-
Dydrogesterone APIDydrogesterone API (CAS 152-62-5) is a highly selective progestogen API, mainly used for the treatment of female endocrine and reproductive system disorders. It specifically binds to progesteroneread more
-
Retatrutide APIRetatrutide API (CAS 2381089-83-2), a first-in-class peptide GLP-1/GIP/GCG triple receptor agonist developed by Eli Lilly, is a breakthrough API for the treatment of type 2 diabetes and obesity.read more
-
Orforglipron APIOrforglipron API (CAS 2212020-52-3) is a pioneering oral non-peptide small-molecule GLP-1 receptor agonist developed by Eli Lilly. As a breakthrough Orforglipron raw material (API) for type 2read more
Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity....
Jan 2, 2024 · Chemsrc provides Cagrilintide (CAS#:1415456-99-3) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of Cagrilintide are included as well....
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide...
Cagrilintide is a non-selective AMYR/CTR agonist and long-acting acylated amylase analogue. CagriSema is combined with Cagrilintide and Semaglutide. The clinical phase II trial of...
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide...
Patients treated with Kaglinide experience a decrease in appetite, which helps sustain weight loss and improves blood sugar control. Kaglinide's ability to enhance satiety makes it a valuable...
